Results indicate that IL20RB is more likely to act as a cytokine receptor, and tumor samples with high IL20RB expression are more likely to enrich pathways related to immune response such as cytokine-cytokine receptor interaction and intestinal immune network for IgA production. Here, CD79A is linked to neoplasm.